A novel ANK1 gene mutation associated with hereditary spherocytosis: a case report

• by Mingqian Lai, Zhengqiang Luo, Zhenyu Yang, Ronghua Pan, Weijun Huang, Wensen Zhang, Guoda Ma, Riling Chen

• May 29, 2026

Merging evans syndrome with mucopolysaccharidosis type II: a case report

• by Xinrui Wang, Jing Zhang, Yanhui Tang, Chunyan Liu, Peng Hu, You Yang, Hongying Chen

• May 4, 2026

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• by

• December 17, 2025

• 4 min

Clinical Findings in Migrants With Asymptomatic Plasmodium Infections

• by Isabelle Eliasson, Katja Wyss, Rebecca Tafesse Bogale, Sofia Forsblom, Emil Lindquist, Caroline Rönnberg, Magnus Hansson, Soheir Beshara, Irene Nordling, Olof Hertting, Andreas Wångdahl, Anna Färnert

• September 2, 2025